If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Tuesday broker round-up UPDATE

Tue, 10th Sep 2013 08:17
African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell.Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral.AstraZeneca: Jefferies reduces target price from 3400p to 3200p, while keeping its hold recommendation.Barclays: Alphavalue shifts target price from 342.10p to 341.70p downgrading from buy to add.Betfair: Deutsche Bank raises target price from 884p to 945p staying with its hold recommendation. Citi takes target price from 975p to 1150p and reiterates a buy recommendation.BG Group: Morgan Stanley cuts target price from 1400p to 1370p and retains an overweight rating.Billington Holdings: WH Ireland raises target price from 70p to 125p and maintains a buy recommendation.British Sky Broadcasting: Goldman Sachs ups target price from 1010p to 1170p and reiterates a strong buy recommendation.Centamin: Investec moves target price from 45.60p to 50p keeping its buy recommendation.Craneware: Investec places both its target price (prev.: 365p) and its buy recommendation under review. N+1 Singer downgrades to hold with a target price of 375p.Daily Mail & General Trust: Goldman Sachs raises target price from 695p to 780p, but still recommends selling.Darty: Alphavalue shifts target price from 73.20p to 73.80p and upgrades from sell to reduce.Eland Oil & Gas: Canaccord Genuity lowers target price from 180p to 173p, while leaving its buy recommendation unchanged.Evraz: JP Morgan reduces target price from 252p to 116p keeping its underweight rating.Fenner: Investec ups target price from 330p to 370p and stays with its hold recommendation.GlaxoSmithKline: Jefferies cuts target price from 1825p to 1800p maintaining a hold recommendation.Hilton Food Group: Investec placet both its target price (prev.: 352p) and its add rating under review. Panmure Gordon ups target price from 450p to 480p and keeps a buy recommendation.IGas Energy: Canaccord Genuity moves target price from 174p to 181p retaining a buy recommendation.Intertek Group: Deutsche Bank increases target price from 2820p to 3243p reiterating a hold recommendation.ISG: WH Ireland moves target price from 240p to 250p and reiterates its buy recommendation.Ithaca Energy: Liberum Capital initiates with a target price of 210p and a buy recommendation.Lonmin: JP Morgan takes target price from 330p to 400p and maintains an overweight rating. Citi ups target price from 374p to 418p keeping a buy recommendation.Moneysupermarket: Westhouse Securities downgrades to add with a target price of 195p.Oxford Instruments: Investec ups target price from 1320p to 1500p, while its hold recommendation remains unaltered.Randgold Resources: Investec increases target price from 4981p to 5018p leaving its hold recommendation unchanged.Regus: Panmure Gordon takes target price from 200p to 250p and stays with its buy recommendation.Rio Tinto: JP Morgan raises target price from 4200p to 4300p reiterating an overweight rating.SABMiller: HSBC increases target price from 3400p to 3600p upgrading to overweight.SSE: Morgan Stanley ups target price from 1185p to 1280p, while leaving its underweight rating unchanged.Surgical Innovations: Panmure Gordon shifts target price from 6.60p to 7.60p, while its buy recommendation remains unaltered.Unilever: Deutsche Bank raises target price from 2590p to 2800p upgrading to buy.WPP Group: Goldman Sachs increases target price from 1340p to 1600p and keeps a buy recommendation. Berenberg ups target price from 1050p to 1085p, but still recommends selling. Astrazeneca Barclays Rio Tinto Unilever Hilton Foods Oxford Instruments SSE Evraz Craneware Glaxosmithkline WPP Surgical Innovations Moneysupermarket.Com Intertek Group Billington

Shares in this article

Related News

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
9 hours ago

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

* NICE ⁠previously denied NHS coverage for ​Enhertu over cost-effectiveness concerns

LONDON MARKET CLOSE: Stocks down, oil up as Trump says ceasefire over
10 hours ago

LONDON MARKET CLOSE: Stocks down, oil up as Trump says ceasefire over

(Alliance News) - Stocks plummeted on Wednesday as tensions flared in the Middle East with the US threatening further attacks on Iran.

Market News BP + 13 more shares
PRESS: AstraZeneca and Daiichi near UK Enhertu price deal - Bloomberg
13 hours ago

PRESS: AstraZeneca and Daiichi near UK Enhertu price deal - Bloomberg

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd are progressing towards a deal which could bring access to breast cancer drug Enhertu for ...